Predictive Medicine Means "Ten Years of Bad News"
This article was originally published in RPM Report
Executive Summary
FDA expects pharmacogenomics to help turn around drug development. But one researcher says the first decade of applying the tenchonology will focus almost exclusively on limiting markets.